Dr. Emily McDonald 

Dr. Emily McDonald is a member of the AOC and Co-Chair of the ACT Communications Working Group. She is an early career researcher at McGill University and the Scientific Director of the Canadian Deprescribing Network. She has published >110 peer-reviewed manuscripts in journals such as NEJM, JAMA Network, and BMJ (including 7 RCTs). She has received ~$4M in funding for the conduct of RCTs in medication appropriateness and optimal treatment of infectious diseases. She has supervised >30 HQP. She was the recipient of the McGill Department of Medicine Early Career Investigator award (2020) and the Canadian Society of Internal Medicine New Investigator award (2017).

The Accelerating Clinical Trials Consortium is generously supported through multi-year funding from the Canadian Institutes of Health Research’s Clinical Trials Fund, as part of Canada’s Biomanufacturing and Life Sciences Strategy to ensure that Canadians are well served by a national clinical trials network.